Fig. 1: Clinical utility of genome-wide molecular stratification of patients with esophageal adenocarcinoma (EAC). | Oncogene

Fig. 1: Clinical utility of genome-wide molecular stratification of patients with esophageal adenocarcinoma (EAC).

From: Molecular stratification of esophageal adenocarcinoma: implications for prognosis and treatment strategy

Fig. 1

In this review, studies on EAC were categorized according to the clinical questions they address, either the stratification’s value for prognostication or impact on therapy selection. Several studies combined therapeutic decisions with prognostic assessment of the patients. Particularly relevant examples of subtyping are highlighted. CIMP: CpG island methylator phenotype.

Back to article page